𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Growth suppression and apoptosis induction in synovial sarcoma cell lines by a novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ)

✍ Scribed by Keisuke Horiuchi; Hideo Morioka; Kazumasa Nishimoto; Yoshihisa Suzuki; Michiro Susa; Robert Nakayama; Akira Kawai; Hiroshi Sonobe; Hironari Takaishi; Toshifumi Ozaki; Hiroo Yabe; Kazuo Umezawa; Yoshiaki Toyama

Book ID
116334927
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
429 KB
Volume
272
Category
Article
ISSN
0304-3835

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeting NF-κB and induction of apoptos
Targeting NF-κB and induction of apoptosis by novel NF-κB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) in Burkitt lymphoma cells
✍ Noriko Kimura; Yoshitaka Miyakawa; Kanoko Kohmura; Kazuo Umezawa; Yasuo Ikeda; M 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 401 KB

A new NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), inhibited proliferation and induced apoptosis in human Burkitt lymphoma, HS-Sultan and Daudi cell lines. The activation of caspase-3 and the cleavage of caspase substrate PARP were observed after treatment with DHMEQ. The induction o

Effects of a novel NF-κB inhibitor, dehy
Effects of a novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on growth, apoptosis, gene expression, and chemosensitivity in head and neck squamous cell carcinoma cell lines
✍ Hong-ying Ruan; Muneyuki Masuda; Aya Ito; Kazuo Umezawa; Torahiko Nakashima; Ryu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

## Background: Recent studies provide evidence that the constitutive activation of nuclear factor-kappa b, nf-kappab plays a critical role in enhancing the growth of several types of malignancies, including head and neck squamous cell carcinoma (hnscc). ## Methods: In this study, we examined the

A novel NF-κB inhibitor DHMEQ selectivel
A novel NF-κB inhibitor DHMEQ selectively targets constitutive NF-κB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo
✍ Mariko Watanabe; Md. Zahidunnabi Dewan; Takamitu Okamura; Masataka Sasaki; Kinji 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 453 KB

Multiple myeloma (MM) is a fatal lymphoid malignancy that is incurable with conventional modalities of chemotherapy. Strong and constitutive activation of nuclear factor kappa B (NF-kappaB) is a common characteristic of MM cells. In our study we successfully target NF-kappaB with a novel NF-kappaB i